Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN Big Pharma
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Opportunity Scholar Nadia Manushev pursues career in optometry through the Department of Biology’s 3+4 program
Manushev, who speaks Bulgarian and Spanish, was also a member of the Bridge Program before starting her studies at UMSL.
MORE IN Big Pharma
LATEST NEWS
- Opportunity Scholar Nadia Manushev pursues career in optometry through the Department of Biology’s 3+4 program
- At Greater St. Louis, Inc., UMSL alum Kylee Garretson attracts companies to invest in St. Louis
- UMSL’s Advanced Workforce Center delivers diverse pathways to prepare the workforce of tomorrow
- Eye on UMSL: Banging the drum for peace
- College of Nursing hosts escape room simulation focused on infection prevention training
- New NextGen Leaders program aims to prepare students to become changemakers in their communities
- UMSL Innovation Center celebrates official grand opening
- Entrepreneur of the Year Awards shine in newly renovated UMSL Innovation Center
- STLCyberCon explores some of the latest trends in the world of cybersecurity
- 3 questions with Karen Boleska, director of the sport management program
